Iudaev N A, Smirnova N B
Vopr Med Khim. 1976 Sep-Oct;22(5):673-8.
Trace amounts of labelled pregnenolone were added to the slices of veriliscent tumor from human adrenal gland in order to study the stepwise conversion of the steroid into androstenedione, 11betaOH-androstenedione and their intermediats--17-alpha-OH pregnenolone, dehydroepiandrosterone, progesterone, and 17-alpha-OH-progesterone. The definite sequence was observed in the maximal incorporation of pregnenolone label into 17-alpha-OH-pregnenolone (2-5 min of incubation) leads to dehydroepiandrosterone (5-15 min) leads to androstenedione (10-20 min). Incorporation of the pregnenolone label into 17-alpha-OH-pregnenolone and dehydroepiandrosterone was distinctly higher than into progesterone and 17-alpha-OH-progesterone in all the experiments within all the studied periods of incubation. The data obtained suggest that in viriliscent tumors of adrenal gland conversion of pregnenolone into androgens proceeded as follows: pregnenolone leads to 17-alpha-OH-pregnenolone leads to dehydroepiandrosterone leads to androstenedione. When formation of androstenedione and 11beta-OH-androstenedione from pregnenolone and progesterone was analyzed during the experiment it was shown that 11-beta-OH-androstenedione was mainly formed via androstenedione and the hormone was the end product of the androgen synthesis.
为了研究甾体逐步转化为雄烯二酮、11β-羟基雄烯二酮及其中间体——17α-羟基孕烯醇酮、脱氢表雄酮、孕酮和17α-羟基孕酮的过程,向人肾上腺男性化肿瘤切片中添加了微量标记的孕烯醇酮。观察到孕烯醇酮标记物最大掺入量的明确顺序为:先掺入17α-羟基孕烯醇酮(孵育2 - 5分钟),再到脱氢表雄酮(5 - 15分钟),最后到雄烯二酮(10 - 20分钟)。在所有研究的孵育时间段内的所有实验中,孕烯醇酮标记物掺入17α-羟基孕烯醇酮和脱氢表雄酮的量明显高于掺入孕酮和17α-羟基孕酮的量。所获得的数据表明,在肾上腺男性化肿瘤中,孕烯醇酮向雄激素的转化过程如下:孕烯醇酮→17α-羟基孕烯醇酮→脱氢表雄酮→雄烯二酮。在实验过程中分析从孕烯醇酮和孕酮形成雄烯二酮和11β-羟基雄烯二酮的情况时发现,11β-羟基雄烯二酮主要通过雄烯二酮形成,且该激素是雄激素合成的终产物。